1. Home
  2. ELDN vs ABAT Comparison

ELDN vs ABAT Comparison

Compare ELDN & ABAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELDN
  • ABAT
  • Stock Information
  • Founded
  • ELDN 2004
  • ABAT 2011
  • Country
  • ELDN United States
  • ABAT United States
  • Employees
  • ELDN N/A
  • ABAT N/A
  • Industry
  • ELDN Biotechnology: Pharmaceutical Preparations
  • ABAT Metal Mining
  • Sector
  • ELDN Health Care
  • ABAT Basic Materials
  • Exchange
  • ELDN Nasdaq
  • ABAT Nasdaq
  • Market Cap
  • ELDN 202.4M
  • ABAT 232.2M
  • IPO Year
  • ELDN N/A
  • ABAT N/A
  • Fundamental
  • Price
  • ELDN $2.37
  • ABAT $2.49
  • Analyst Decision
  • ELDN Strong Buy
  • ABAT
  • Analyst Count
  • ELDN 2
  • ABAT 0
  • Target Price
  • ELDN $12.50
  • ABAT N/A
  • AVG Volume (30 Days)
  • ELDN 640.2K
  • ABAT 3.4M
  • Earning Date
  • ELDN 11-11-2025
  • ABAT 11-14-2025
  • Dividend Yield
  • ELDN N/A
  • ABAT N/A
  • EPS Growth
  • ELDN N/A
  • ABAT N/A
  • EPS
  • ELDN 0.21
  • ABAT N/A
  • Revenue
  • ELDN N/A
  • ABAT $1,857,877.00
  • Revenue This Year
  • ELDN N/A
  • ABAT $718.34
  • Revenue Next Year
  • ELDN N/A
  • ABAT $1,505.37
  • P/E Ratio
  • ELDN $11.10
  • ABAT N/A
  • Revenue Growth
  • ELDN N/A
  • ABAT N/A
  • 52 Week Low
  • ELDN $2.32
  • ABAT $0.73
  • 52 Week High
  • ELDN $5.54
  • ABAT $4.11
  • Technical
  • Relative Strength Index (RSI)
  • ELDN 35.17
  • ABAT 52.87
  • Support Level
  • ELDN $2.41
  • ABAT $2.26
  • Resistance Level
  • ELDN $2.84
  • ABAT $2.77
  • Average True Range (ATR)
  • ELDN 0.13
  • ABAT 0.18
  • MACD
  • ELDN 0.00
  • ABAT -0.02
  • Stochastic Oscillator
  • ELDN 10.48
  • ABAT 47.37

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

About ABAT American Battery Technology Company

American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.

Share on Social Networks: